UBS Maintains Neutral on Cabot, Lowers Price Target to $86

Benzinga Newsdesk www.benzinga.com Negative 85.4%

Neg 85.4% Neu 0% Pos 0%

UBS analyst Joshua Spector maintains Cabot (NYSE:CBT) with a Neutral and lowers the price target from $92 to $86.

Comments

No comments yet. Be the first!